Cognex director sells 44,000 shares at $54

Cognex director Dianne M. Parrotte exercised multiple non-qualified stock options on March 2, 2026 and immediately sold the resulting shares.

Accepted by SEC EDGAR 03/03/2026 - 04:28 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Cognex director Dianne M. Parrotte exercised multiple non-qualified stock options on March 2, 2026 and immediately sold the resulting shares. She acquired 44,000 shares of Cognex common stock through option exercises at strike prices around $45–$51.49, then sold 44,000 shares in open-market transactions at $54.00 per share. After these transactions, she directly owned 33,431 Cognex common shares.

Insider Trade Summary

Exercise and Sale: 44,000 shares ($169K approx. pre-tax spread)

Exercise and Sale 12 txns

Insider PARROTTE DIANNE M

Role Director

Sold 44,000 shs ($2.38M)

Approx. gross sale proceeds $2.38M

Approx. exercise cost $2.21M

Approx. pre-tax spread $169K

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	7,500	$0.00	$0.00
Exercise	Non-Qualified Stock Option (right to buy)	18,400	$0.00	$0.00
Exercise	Non-Qualified Stock Option (right to buy)	2,500	$0.00	$0.00
Exercise	Non-Qualified Stock Option (right to buy)	15,600	$0.00	$0.00
Exercise	Common Stock	2,500	$51.49	$129K
Sale	Common Stock	2,500	$54.00	$135K
Exercise	Common Stock	15,600	$51.49	$803K
Sale	Common Stock	15,600	$54.00	$842K
Exercise	Common Stock	7,500	$45.06	$338K
Sale	Common Stock	7,500	$54.00	$405K
Exercise	Common Stock	18,400	$50.94	$937K
Sale	Common Stock	18,400	$54.00	$994K

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 15,600 contracts (Direct); Common Stock — 33,431 shares (Direct)

Footnotes (4)

1. F1. The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (May 2, 2018).
2. F2. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020).
3. F3. These Stock Options were granted on February 19, 2019. 10,000 stock options vest in four equal annual installments beginning May 2, 2019. 26,000 stock options vest in five equal installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
4. F4. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cognex (CGNX) director Dianne Parrotte do in this Form 4 filing?

Dianne M. Parrotte exercised Cognex stock options and sold the resulting shares. She converted options into 44,000 common shares, then sold 44,000 shares in open-market trades, ending with 33,431 shares held directly.

How many Cognex (CGNX) shares did the director sell and at what price?

The director sold 44,000 Cognex common shares in open-market transactions at $54.00 per share. These sales followed option exercises that converted derivative awards into common stock on the same date.

How many Cognex (CGNX) shares does the director own after these transactions?

After completing the option exercises and related sales, Dianne M. Parrotte directly owns 33,431 Cognex common shares. This figure reflects her updated beneficial ownership position reported as of the transaction date.

Were the Cognex (CGNX) transactions option exercises or open-market buys?

The filing shows option exercises and subsequent sales, not open-market purchases. The director exercised non-qualified stock options to acquire shares, then sold an equal number of shares in open-market transactions at $54.00.

What types of securities were involved in the Cognex (CGNX) director’s transactions?

The transactions involved non-qualified stock options and common stock. Options granted in prior years were exercised to acquire common shares, which were then sold in open-market trades on the same date.

Do the Cognex (CGNX) director’s option grants have vesting schedules?

Yes. Footnotes explain the options vest in four or five equal annual installments following their grant dates in 2018, 2019, and 2020, reflecting multi-year equity incentive awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PARROTTE DIANNE M

(Last) (First) (Middle)

ONE VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		M		2,500	A	$51.49	35,931	D
Common Stock	03/02/2026		S		2,500	D	$54	33,431	D
Common Stock	03/02/2026		M		15,600	A	$51.49	49,031	D
Common Stock	03/02/2026		S		15,600	D	$54	33,431	D
Common Stock	03/02/2026		M		7,500	A	$45.06	40,931	D
Common Stock	03/02/2026		S		7,500	D	$54	33,431	D
Common Stock	03/02/2026		M		18,400	A	$50.94	51,831	D
Common Stock	03/02/2026		S		18,400	D	$54	33,431	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$45.06	03/02/2026		M			7,500	05/02/2019(1)	05/02/2028	Common Stock	7,500	$0.0	0	D
Non-Qualified Stock Option (right to buy)	$50.94	03/02/2026		M			18,400	02/18/2021(2)	02/18/2030	Common Stock	18,400	$0.0	0	D
Non-Qualified Stock Option (right to buy)	$51.49	03/02/2026		M			2,500	05/02/2019(3)	02/19/2029	Common Stock	2,500	$0.0	15,600	D
Non-Qualified Stock Option (right to buy)	$51.49	03/02/2026		M			15,600	02/19/2020(4)	02/19/2029	Common Stock	15,600	$0.0	0	D

Explanation of Responses:

1. The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (May 2, 2018).

2. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020).

3. These Stock Options were granted on February 19, 2019. 10,000 stock options vest in four equal annual installments beginning May 2, 2019. 26,000 stock options vest in five equal installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).

4. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).

	Dianne M. Parrotte	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.